Ten-year survival after first-ever stroke in the perth community stroke study.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 12843343)

Published in Stroke on July 03, 2003

Authors

Kate Hardie1, Graeme J Hankey, Konrad Jamrozik, Robyn J Broadhurst, Craig Anderson

Author Affiliations

1: School of Population Health, University of Western Australia.

Associated clinical trials:

Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) (ERICH) | NCT01202864

Articles citing this

Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer (2010) 1.38

Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry (2005) 1.30

The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking. Cost Eff Resour Alloc (2007) 1.02

Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol (2008) 0.99

Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-years. Stroke (2011) 0.89

Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates. Can J Surg (2008) 0.89

Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol (2007) 0.84

Antiplatelet therapy in populations at high risk of atherothrombosis. J Natl Med Assoc (2006) 0.84

Primary prevention for risk factors of ischemic stroke with Baduanjin exercise intervention in the community elder population: study protocol for a randomized controlled trial. Trials (2014) 0.82

An economic model of long-term use of celecoxib in patients with osteoarthritis. BMC Gastroenterol (2007) 0.81

Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J Neurol Neurosurg Psychiatry (2006) 0.79

The prognostic factors that influence long-term survival in acute large cerebral infarction. J Korean Neurosurg Soc (2011) 0.78

Cost-effectiveness of catheter ablation for rhythm control of atrial fibrillation. Int J Vasc Med (2013) 0.78

Stroke Best Practices: a team approach to evidence-based care. J Natl Med Assoc (2004) 0.75

Administrative data linkage to evaluate a quality improvement program in acute stroke care, Georgia, 2006-2009. Prev Chronic Dis (2015) 0.75

Outdoor air pollution as a possible modifiable risk factor to reduce mortality in post-stroke population. Neural Regen Res (2017) 0.75

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage. BMC Neurol (2008) 0.75

Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009. J Stroke Cerebrovasc Dis (2013) 0.75

Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation. CMAJ Open (2017) 0.75

Articles by these authors

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99

Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04

Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet (2012) 10.30

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.87

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet (2002) 5.27

Developing a reliable audit instrument to measure the physical environment for physical activity. Am J Prev Med (2002) 4.27

Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients. Anesth Analg (2003) 4.15

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation (2012) 4.10

Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med (2007) 3.97

Unsafe driving behaviour and four wheel drive vehicles: observational study. BMJ (2006) 3.69

Developing a framework for assessment of the environmental determinants of walking and cycling. Soc Sci Med (2003) 3.63

Early supported discharge services for stroke patients: a meta-analysis of individual patients' data. Lancet (2005) 3.56

Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions: we need processes in place to follow up suspicions about serious adverse events. Med J Aust (2004) 3.34

In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. J Clin Endocrinol Metab (2013) 3.11

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol (2010) 2.81

Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ (2004) 2.70

Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke (2002) 2.57

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56

Preliminary results of the Australasian Regional Anaesthesia Collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications. Reg Anesth Pain Med (2009) 2.54

Neighborhood environmental factors correlated with walking near home: Using SPACES. Med Sci Sports Exerc (2006) 2.49

Hard lessons from a randomised controlled trial. Med J Aust (2002) 2.45

Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens (2006) 2.37

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37

Rates of pediatric injuries by 3-month intervals for children 0 to 3 years of age. Pediatrics (2003) 2.35

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet (2011) 2.35

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J (2011) 2.31

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J (2004) 2.25

Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23

Venous thromboembolism: diagnosis and management of pulmonary embolism. Med J Aust (2005) 2.20

The Stroke Riskometer(TM) App: validation of a data collection tool and stroke risk predictor. Int J Stroke (2014) 2.18

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). J Am Coll Cardiol (2013) 2.17

Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc (2010) 2.16

Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol (2006) 2.11

Low molecular weight heparins and heparinoids. Med J Aust (2002) 2.06

Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05

Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab (2009) 2.01

Are the national guidelines for health behaviour appropriate for older Australians? Evidence from the Men, Women and Ageing project. Australas J Ageing (2010) 2.01

Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol (2009) 2.01

Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ (2012) 1.86

Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81

Efficacy and safety of vorapaxar in patients with prior ischemic stroke. Stroke (2013) 1.79

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding. Ann Intern Med (2009) 1.76

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol (2012) 1.76

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev (2012) 1.72

Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ (2006) 1.71

Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens (2007) 1.69

A brave new world for an old world pest: Helicoverpa armigera (Lepidoptera: Noctuidae) in Brazil. PLoS One (2013) 1.68

Prevalence of sexual activity and associated factors in men aged 75 to 95 years: a cohort study. Ann Intern Med (2010) 1.67

150 minutes of vigorous physical activity per week predicts survival and successful ageing: a population-based 11-year longitudinal study of 12 201 older Australian men. Br J Sports Med (2013) 1.67

Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol (2010) 1.65

Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke (2010) 1.62

Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial. J Hypertens (2013) 1.62

Cognitive impairment and risk of cardiovascular events and mortality. Eur Heart J (2012) 1.60

The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust (2008) 1.57

Anticipated behaviors of emergency prehospital medical care providers during an influenza pandemic. Prehosp Disaster Med (2010) 1.56

Alcohol use and mortality in older men and women. Addiction (2010) 1.55

Effectiveness of screening for risk of medical emergencies in the elderly. Age Ageing (2005) 1.54

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Circulation (2014) 1.54

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. Eur Heart J (2013) 1.53

A consensus on stroke: early supported discharge. Stroke (2011) 1.52

Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke (2008) 1.52

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51

A prospective evaluation of emergency department bedside ultrasonography for the detection of acute cholecystitis. Ann Emerg Med (2010) 1.51

Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke (2004) 1.50

Is bupropion (Zyban) causing deaths? Med J Aust (2002) 1.50

Preexisting cognitive impairment is associated with postoperative cognitive dysfunction after hip joint replacement surgery. Anesthesiology (2015) 1.50

The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease. Eur Heart J (2009) 1.49

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials (2011) 1.49

Socioeconomic disparities in stroke rates and outcome: pooled analysis of stroke incidence studies in Australia and New Zealand. Med J Aust (2011) 1.48

Incidence of stroke in women in Auckland, New Zealand. Ethnic trends over two decades: 1981-2003. N Z Med J (2006) 1.48

Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol (2008) 1.47

The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer (2004) 1.47

Alcohol consumption and male erectile dysfunction: an unfounded reputation for risk? J Sex Med (2009) 1.46

Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients. Stroke (2006) 1.46

Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry (2007) 1.46

Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men. Clin Endocrinol (Oxf) (2013) 1.45

Changes in maternal marital status are associated with young adults' cannabis use: evidence from a 21-year follow-up of a birth cohort. Int J Epidemiol (2006) 1.45

Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke (2009) 1.43

Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region. Eur J Cardiovasc Prev Rehabil (2008) 1.43

A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42

Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin. J Hypertens (2002) 1.42

Assessing the effectiveness of a mammography screening service. ANZ J Surg (2005) 1.40